Logo

U Pitt Team to Use Wafergen’s Whole-Genome RT-PCR Platform for Biomarker Studies

Nov 13, 2007
NEW YORK (GenomeWeb News) — The University of Pittsburgh Medical School will serve as the alpha test site for Wafergen Biosystem’s real-time PCR system, Wafergen said today.
 
Through a research collaboration with a team led by Department of Medicine Chairman Steven Shapiro, the school will use the WaferGen SmartChip Real-Time PCR System in its efforts to identify biomarkers that are therapeutically useful for chronic obstructive pulmonary disease and for lung cancer.
 
Wafergen said the SmartChip “is designed as the first whole-genome, high-throughput gene expression real-time polymerase chain reaction platform.”
 
Financial terms of the collaboration were not released.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.